Harris Associates Portfolio holdings
Top Buys
| 1 |
Reinsurance Group of America
RGA
|
+$263M |
| 2 |
Workday
WDAY
|
+$221M |
| 3 |
HCA Healthcare
HCA
|
+$214M |
| 4 |
EOG Resources
EOG
|
+$140M |
| 5 |
General Dynamics
GD
|
+$128M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$619M |
| 2 |
General Motors
GM
|
+$340M |
| 3 |
TE Connectivity
TEL
|
+$228M |
| 4 |
Charter Communications
CHTR
|
+$220M |
| 5 |
Stellantis
STLA
|
+$206M |
Sector Composition
| 1 | Financials | 26.13% |
| 2 | Communication Services | 25.03% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Healthcare | 8.84% |
| 5 | Technology | 8.5% |
Similar funds
Harris Associates's Q2 2020 Portfolio in Review
As of Q2 2020, Harris Associates held 139 positions worth $41.1B, up 14% from $36.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Harris Associates withdrew a net $2.83B in Q2 2020, closing 7 positions and reducing 88 holdings. Its most notable exit was Delphi Technologies PLC Ordinary Shares, an estimated $28.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Harris Associates opened a new position in General Dynamics worth $135M.
- Harris Associates's largest Q2 2020 buy was General Dynamics: 905,869 shares worth $135M.
- Harris Associates added most to Reinsurance Group of America in Q2 2020, an estimated $263M increase.
- Harris Associates's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $619M.
- Harris Associates fully exited Delphi Technologies PLC Ordinary Shares in Q2 2020, selling an estimated $28.5M.
- Harris Associates's ten largest holdings make up 34% of its $41.1B portfolio in Q2 2020.
- Harris Associates opened 10 new positions and closed 7 in Q2 2020.
- Harris Associates's portfolio value rose 14% quarter-over-quarter to $41.1B.
Based on Harris Associates's 13F filing for Q2 2020, filed 14 Aug 2020.